TY  -  
T1  - Outcome of intracerebral hemorrhage associated with different oral anticoagulants 
SN  -  /  
UR  - http://hdl.handle.net/10138/195658 
T3  -  
A1  - Wilson, Duncan; Seiffge, David J.; Traenka, Christopher; Basir, Ghazala; Purrucker, Jan C.; Rizos, Timolaos; Sobowale, Oluwaseun A.; Sallinen, Hanne; Yeh, Shin-Joe; Wu, Teddy Y.; Ferrigno, Marc; Houben, Rik; Schreuder, Floris H. B. M.; Perry, Luke A.; Tanaka, Jun; Boulanger, Marion; Salman, Rustam Al-Shahi; Jaeger, Hans R.; Ambler, Gareth; Shakeshaft, Clare; Yakushiji, Yusuke; Choi, Philip M. C.; Staals, Julie; Cordonnier, Charlotte; Jeng, Jiann-Shing; Veltkamp, Roland; Dowlatshahi, Dar; Engelter, Stefan T.; Parry-Jones, Adrian R.; Meretoja, Atte; Werring, David J.; CROMIS-2 Collaborators 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - Objective: In an international collaborative multicenter pooled analysis, we compared mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma expansion (HE) between non-vitamin K antagonist oral anticoagulation-related ICH (NOAC-ICH) and vitamin K antagonist-associated ICH (VKA-ICH). Methods: We compared all-cause mortality within 90 days for NOAC-ICH and VKA-ICH using a Cox proportional hazards model adjusted for age; sex; baseline Glasgow Coma Scale score, ICH locati... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - THROMBIN INHIBITOR DABIGATRAN; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; WARFARIN; TRIAL; REVERSAL; RIVAROXABAN; VOLUME; IDARUCIZUMAB; MANAGEMENT; 3112 Neurosciences; 3124 Neurology and psychiatry 
N1  -   
PP  -  
ER  -